These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2652727)

  • 1. Cyclosporine induced hemolytic anemia in a liver transplant patient.
    Faure JL; Causse X; Bergeret A; Meyer F; Neidecker J; Paliard P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2242-3. PubMed ID: 2652727
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune hemolytic anemia during treatment with cyclosporin after liver transplantation].
    Causse X; Meyer F; Bergeret A; Faure JL; Paliard P
    Gastroenterol Clin Biol; 1988 Mar; 12(3):262-4. PubMed ID: 3286357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine-associated microangiopathic hemolytic anemia in a renal transplant recipient.
    Yoshimura N; Oka T; Ohmori Y; Aikawa I; Yasumura T; Matsui S; Hamashima T; Lee CJ
    Jpn J Surg; 1989 Mar; 19(2):223-8. PubMed ID: 2657153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

  • 6. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.
    Van Buren D; Van Buren CT; Flechner SM; Maddox AM; Verani R; Kahan BD
    Surgery; 1985 Jul; 98(1):54-62. PubMed ID: 3892747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoimmune hemolytic anemia caused by anti-D antibody and a lymphoproliferative process in a patient with a kidney transplant immunosuppressed with cyclosporine].
    Oyonarte S; Cabello M; Clavero C; García Corzo G; Maldonado J
    Med Clin (Barc); 1988 Apr; 90(13):545-7. PubMed ID: 2839744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe hemolysis during immunosuppressive therapy with cyclosporin A following kidney transplantation].
    Kirste G; Wilms H; Hörl W; Steinhauer HB
    Dtsch Med Wochenschr; 1985 Apr; 110(16):655-6. PubMed ID: 3886342
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid abnormalities in renal transplant recipients treated with cyclosporine.
    Vathsala A; Weinberg RB; Schoenberg L; Grevel J; Dunn J; Goldstein RA; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1989 Aug; 21(4):3670-3. PubMed ID: 2669278
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
    Miller RA; Shen JY; Rea TH; Harnisch JP
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic anemias induced by drugs].
    Durán-Suárez JR
    Med Clin (Barc); 1984 May; 82(18):816-21. PubMed ID: 6234441
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A.
    Stewart KN; Power DA; Hills AN; Catto GR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078
    [No Abstract]   [Full Text] [Related]  

  • 14. Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
    Vincent HH; Wenting GJ; Jeekel J; Schalekamp MA; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1737-8. PubMed ID: 3274419
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine in cardiac transplantation.
    Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
    Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of cyclosporine therapy following liver transplantation.
    Grant D; Wall W; Duff J; Stiller C; Ghent C; Keown P
    Transplant Proc; 1987 Aug; 19(4):3463-5. PubMed ID: 3303518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hope in the treatment of systemic lupus erythematosus by cyclosporin in hematologic forms resistant to corticoids and splenectomy].
    Camsonne R; Troussard X; Macro M; Le Porrier M; Moulin MA
    Therapie; 1986; 41(2):147-8. PubMed ID: 3726791
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantation.
    de Groen PC; Wiesner RH; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2456. PubMed ID: 2652803
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenacetin-induced immune hemolytic anemia of the so-called innocent bystander reaction type].
    Boustani A; Michot F
    Schweiz Med Wochenschr; 1970 Sep; 100(39):1650-2. PubMed ID: 5513815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.